A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the continued use of ipilimumab in patients who had
reinduction at the time of disease progression or to continue maintenance treatment. In
addition, this study will continue to follow patients who have taken ipilimumab, but who are
not eligible for maintenance or reinduction therapy.